{"frames":[{"target":{"name":"Progress","spans":[{"start":0,"end":1,"text":"Progress"}]},"annotationSets":[{"rank":0,"score":59.02742079999205,"frameElements":[]}]},{"target":{"name":"Research","spans":[{"start":3,"end":4,"text":"research"}]},"annotationSets":[{"rank":0,"score":54.58830430289186,"frameElements":[]}]}],"tokens":["Progress","in","lipid","research","."]}
{"frames":[{"target":{"name":"Medical_conditions","spans":[{"start":6,"end":7,"text":"health"}]},"annotationSets":[{"rank":0,"score":34.091285449713354,"frameElements":[]}]},{"target":{"name":"Medical_conditions","spans":[{"start":8,"end":9,"text":"disease"}]},"annotationSets":[{"rank":0,"score":33.88193142037607,"frameElements":[]}]},{"target":{"name":"Relative_time","spans":[{"start":10,"end":11,"text":"Recent"}]},"annotationSets":[{"rank":0,"score":19.295933932585516,"frameElements":[]}]},{"target":{"name":"Progress","spans":[{"start":11,"end":12,"text":"advances"}]},"annotationSets":[{"rank":0,"score":54.76703491226494,"frameElements":[]}]}],"tokens":["Sphingosine","1-phosphate","and","sphingosine","kinases","in","health","and","disease",":","Recent","advances","."]}
{"frames":[{"target":{"name":"Creating","spans":[{"start":10,"end":11,"text":"formation"}]},"annotationSets":[{"rank":0,"score":87.39423825174121,"frameElements":[{"name":"Created_entity","spans":[{"start":11,"end":15,"text":"of a bioactive lipid"}]}]}]},{"target":{"name":"Natural_features","spans":[{"start":13,"end":14,"text":"bioactive"}]},"annotationSets":[{"rank":0,"score":33.64854724183453,"frameElements":[{"name":"Locale","spans":[{"start":14,"end":15,"text":"lipid"}]}]}]}],"tokens":["Sphingosine","kinases","-LRB-","isoforms","SK1","and","SK2","-RRB-","catalyse","the","formation","of","a","bioactive","lipid",",","sphingosine","1-phosphate","-LRB-","S1P","-RRB-","."]}
{"frames":[{"target":{"name":"Kinship","spans":[{"start":7,"end":8,"text":"family"}]},"annotationSets":[{"rank":0,"score":18.78841399265885,"frameElements":[{"name":"Relatives","spans":[{"start":7,"end":8,"text":"family"}]}]}]},{"target":{"name":"Cardinal_numbers","spans":[{"start":9,"end":10,"text":"five"}]},"annotationSets":[{"rank":0,"score":26.76714243500481,"frameElements":[{"name":"Number","spans":[{"start":9,"end":10,"text":"five"}]}]}]},{"target":{"name":"Inclusion","spans":[{"start":17,"end":18,"text":"has"}]},"annotationSets":[{"rank":0,"score":27.7088631741521,"frameElements":[{"name":"Part","spans":[{"start":18,"end":21,"text":"intracellular signalling roles"}]},{"name":"Total","spans":[{"start":6,"end":15,"text":"a family of five S1P-specific G protein coupled receptors"}]}]}]},{"target":{"name":"Performers_and_roles","spans":[{"start":20,"end":21,"text":"roles"}]},"annotationSets":[{"rank":0,"score":46.66157059066255,"frameElements":[]}]}],"tokens":["S1P","is","a","well-established","ligand","of","a","family","of","five","S1P-specific","G","protein","coupled","receptors","but","also","has","intracellular","signalling","roles","."]}
{"frames":[{"target":{"name":"Existence","spans":[{"start":0,"end":2,"text":"There is"}]},"annotationSets":[{"rank":0,"score":54.04626073615779,"frameElements":[{"name":"Entity","spans":[{"start":2,"end":17,"text":"substantial evidence to support a role for sphingosine kinases and SIP in health and disease"}]}]}]},{"target":{"name":"Evidence","spans":[{"start":3,"end":4,"text":"evidence"}]},"annotationSets":[{"rank":0,"score":24.663864554414012,"frameElements":[{"name":"Proposition","spans":[{"start":4,"end":17,"text":"to support a role for sphingosine kinases and SIP in health and disease"}]},{"name":"Support","spans":[{"start":3,"end":4,"text":"evidence"}]},{"name":"Degree","spans":[{"start":2,"end":3,"text":"substantial"}]}]}]},{"target":{"name":"Taking_sides","spans":[{"start":5,"end":6,"text":"support"}]},"annotationSets":[{"rank":0,"score":55.87261475918097,"frameElements":[{"name":"Cognizer","spans":[{"start":2,"end":4,"text":"substantial evidence"}]}]}]},{"target":{"name":"Performers_and_roles","spans":[{"start":7,"end":8,"text":"role"}]},"annotationSets":[{"rank":0,"score":41.659711474105364,"frameElements":[]}]},{"target":{"name":"Ingestion","spans":[{"start":12,"end":13,"text":"SIP"}]},"annotationSets":[{"rank":0,"score":32.85923520973427,"frameElements":[]}]},{"target":{"name":"Medical_conditions","spans":[{"start":14,"end":15,"text":"health"}]},"annotationSets":[{"rank":0,"score":34.091285449713354,"frameElements":[]}]},{"target":{"name":"Medical_conditions","spans":[{"start":16,"end":17,"text":"disease"}]},"annotationSets":[{"rank":0,"score":33.88193142037607,"frameElements":[]}]}],"tokens":["There","is","substantial","evidence","to","support","a","role","for","sphingosine","kinases","and","SIP","in","health","and","disease","."]}
{"frames":[{"target":{"name":"Relative_time","spans":[{"start":3,"end":4,"text":"recent"}]},"annotationSets":[{"rank":0,"score":19.295933932585516,"frameElements":[]}]},{"target":{"name":"Progress","spans":[{"start":4,"end":5,"text":"advances"}]},"annotationSets":[{"rank":0,"score":56.58040279158203,"frameElements":[{"name":"Entity","spans":[{"start":5,"end":8,"text":"in the area"}]}]}]},{"target":{"name":"Locale","spans":[{"start":7,"end":8,"text":"area"}]},"annotationSets":[{"rank":0,"score":46.0364675607122,"frameElements":[{"name":"Locale","spans":[{"start":7,"end":8,"text":"area"}]}]}]},{"target":{"name":"Relation","spans":[{"start":9,"end":10,"text":"relation"}]},"annotationSets":[{"rank":0,"score":12.671645375376473,"frameElements":[{"name":"Entities","spans":[{"start":13,"end":22,"text":"by SIP and novel intracellular targets of this lipid"}]}]}]},{"target":{"name":"Ingestion","spans":[{"start":14,"end":15,"text":"SIP"}]},"annotationSets":[{"rank":0,"score":36.093587835594796,"frameElements":[]}]},{"target":{"name":"Purpose","spans":[{"start":18,"end":19,"text":"targets"}]},"annotationSets":[{"rank":0,"score":31.96791016768192,"frameElements":[]}]}],"tokens":["This","review","summarises","recent","advances","in","the","area","in","relation","to","receptor-mediated","signalling","by","SIP","and","novel","intracellular","targets","of","this","lipid","."]}
{"frames":[{"target":{"name":"Age","spans":[{"start":0,"end":1,"text":"New"}]},"annotationSets":[{"rank":0,"score":44.74122797700984,"frameElements":[{"name":"Age","spans":[{"start":0,"end":1,"text":"New"}]},{"name":"Entity","spans":[{"start":1,"end":2,"text":"evidence"}]}]}]},{"target":{"name":"Evidence","spans":[{"start":1,"end":2,"text":"evidence"}]},"annotationSets":[{"rank":0,"score":28.297016353876693,"frameElements":[{"name":"Proposition","spans":[{"start":2,"end":26,"text":"for a role of each sphingosine kinase isoform in cancer , the cardiovascular system , central nervous system , inflammation and diabetes is discussed"}]}]}]},{"target":{"name":"Performers_and_roles","spans":[{"start":4,"end":5,"text":"role"}]},"annotationSets":[{"rank":0,"score":42.36450402779385,"frameElements":[]}]},{"target":{"name":"Medical_conditions","spans":[{"start":11,"end":12,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":37.097026595515736,"frameElements":[]}]},{"target":{"name":"Gizmo","spans":[{"start":15,"end":16,"text":"system"}]},"annotationSets":[{"rank":0,"score":21.933739493792196,"frameElements":[]}]},{"target":{"name":"Part_orientational","spans":[{"start":17,"end":18,"text":"central"}]},"annotationSets":[{"rank":0,"score":11.132647219422015,"frameElements":[]}]},{"target":{"name":"Experiencer_focus","spans":[{"start":18,"end":19,"text":"nervous"}]},"annotationSets":[{"rank":0,"score":51.49694585441927,"frameElements":[]}]},{"target":{"name":"Gizmo","spans":[{"start":19,"end":20,"text":"system"}]},"annotationSets":[{"rank":0,"score":20.720249084437278,"frameElements":[]}]},{"target":{"name":"Medical_conditions","spans":[{"start":23,"end":24,"text":"diabetes"}]},"annotationSets":[{"rank":0,"score":31.409946575682167,"frameElements":[]}]},{"target":{"name":"Topic","spans":[{"start":25,"end":26,"text":"discussed"}]},"annotationSets":[{"rank":0,"score":21.948350984807654,"frameElements":[{"name":"Topic","spans":[{"start":3,"end":24,"text":"a role of each sphingosine kinase isoform in cancer , the cardiovascular system , central nervous system , inflammation and diabetes"}]}]}]}],"tokens":["New","evidence","for","a","role","of","each","sphingosine","kinase","isoform","in","cancer",",","the","cardiovascular","system",",","central","nervous","system",",","inflammation","and","diabetes","is","discussed","."]}
{"frames":[{"target":{"name":"Existence","spans":[{"start":0,"end":2,"text":"There is"}]},"annotationSets":[{"rank":0,"score":52.05353782494647,"frameElements":[{"name":"Entity","spans":[{"start":2,"end":10,"text":"continued research to develop isoform selective SK inhibitors"}]}]}]},{"target":{"name":"Process_continue","spans":[{"start":2,"end":3,"text":"continued"}]},"annotationSets":[{"rank":0,"score":36.82226265931038,"frameElements":[{"name":"Event","spans":[{"start":4,"end":10,"text":"to develop isoform selective SK inhibitors"}]}]}]},{"target":{"name":"Research","spans":[{"start":3,"end":4,"text":"research"}]},"annotationSets":[{"rank":0,"score":50.46895249246532,"frameElements":[{"name":"Topic","spans":[{"start":4,"end":10,"text":"to develop isoform selective SK inhibitors"}]}]}]},{"target":{"name":"Cause_to_make_progress","spans":[{"start":5,"end":6,"text":"develop"}]},"annotationSets":[{"rank":0,"score":84.67268304236937,"frameElements":[{"name":"Project","spans":[{"start":6,"end":10,"text":"isoform selective SK inhibitors"}]}]}]},{"target":{"name":"Locative_relation","spans":[{"start":12,"end":13,"text":"here"}]},"annotationSets":[{"rank":0,"score":27.523374303478057,"frameElements":[{"name":"Ground","spans":[{"start":12,"end":13,"text":"here"}]}]}]}],"tokens":["There","is","continued","research","to","develop","isoform","selective","SK","inhibitors",",","summarised","here","."]}
{"frames":[{"target":{"name":"Scrutiny","spans":[{"start":0,"end":1,"text":"Analysis"}]},"annotationSets":[{"rank":0,"score":51.32443530811897,"frameElements":[{"name":"Ground","spans":[{"start":1,"end":7,"text":"of the crystal structure of SK1"}]}]}]},{"target":{"name":"Buildings","spans":[{"start":4,"end":5,"text":"structure"}]},"annotationSets":[{"rank":0,"score":44.73390456678934,"frameElements":[{"name":"Building","spans":[{"start":4,"end":5,"text":"structure"}]},{"name":"Function","spans":[{"start":5,"end":7,"text":"of SK1"}]}]}]},{"target":{"name":"Using","spans":[{"start":15,"end":16,"text":"used"}]},"annotationSets":[{"rank":0,"score":121.4494784114989,"frameElements":[{"name":"Instrument","spans":[{"start":0,"end":14,"text":"Analysis of the crystal structure of SK1 with the SK1-selective inhibitor , PF-543 ,"}]},{"name":"Purpose","spans":[{"start":16,"end":34,"text":"to identify residues that could be exploited to improve selectivity in SK inhibitor development for future therapeutic application"}]}]}]},{"target":{"name":"Verification","spans":[{"start":17,"end":18,"text":"identify"}]},"annotationSets":[{"rank":0,"score":64.4635735848645,"frameElements":[{"name":"Unconfirmed_content","spans":[{"start":18,"end":34,"text":"residues that could be exploited to improve selectivity in SK inhibitor development for future therapeutic application"}]}]}]},{"target":{"name":"Capability","spans":[{"start":20,"end":21,"text":"could"}]},"annotationSets":[{"rank":0,"score":42.79155886158621,"frameElements":[{"name":"Event","spans":[{"start":23,"end":34,"text":"to improve selectivity in SK inhibitor development for future therapeutic application"}]},{"name":"Entity","spans":[{"start":19,"end":20,"text":"that"}]}]}]},{"target":{"name":"Cause_to_make_progress","spans":[{"start":24,"end":25,"text":"improve"}]},"annotationSets":[{"rank":0,"score":71.74765680180673,"frameElements":[{"name":"Project","spans":[{"start":25,"end":34,"text":"selectivity in SK inhibitor development for future therapeutic application"}]}]}]},{"target":{"name":"Event","spans":[{"start":29,"end":30,"text":"development"}]},"annotationSets":[{"rank":0,"score":38.346970071904735,"frameElements":[{"name":"Event","spans":[{"start":28,"end":29,"text":"inhibitor"}]}]}]},{"target":{"name":"Temporal_collocation","spans":[{"start":31,"end":32,"text":"future"}]},"annotationSets":[{"rank":0,"score":31.30895084686981,"frameElements":[]}]},{"target":{"name":"Cure","spans":[{"start":32,"end":33,"text":"therapeutic"}]},"annotationSets":[{"rank":0,"score":46.42128084803626,"frameElements":[]}]},{"target":{"name":"Using","spans":[{"start":33,"end":34,"text":"application"}]},"annotationSets":[{"rank":0,"score":93.63436547913994,"frameElements":[]}]}],"tokens":["Analysis","of","the","crystal","structure","of","SK1","with","the","SK1-selective","inhibitor",",","PF-543",",","is","used","to","identify","residues","that","could","be","exploited","to","improve","selectivity","in","SK","inhibitor","development","for","future","therapeutic","application","."]}
{"frames":[],"tokens":["-LRB-","C","-RRB-","2016","Elsevier","Ltd","."]}
{"frames":[{"target":{"name":"Quantity","spans":[{"start":0,"end":1,"text":"All"}]},"annotationSets":[{"rank":0,"score":24.53346865852465,"frameElements":[{"name":"Quantity","spans":[{"start":0,"end":1,"text":"All"}]},{"name":"Individuals","spans":[{"start":1,"end":2,"text":"rights"}]}]}]},{"target":{"name":"Volubility","spans":[{"start":2,"end":3,"text":"reserved"}]},"annotationSets":[{"rank":0,"score":25.053409795442175,"frameElements":[]}]}],"tokens":["All","rights","reserved","."]}
